Identification of a novel inhibitor of mitogen-activated protein kinase kinase

被引:2737
|
作者
Favata, MF
Horiuchi, KY
Manos, EJ
Daulerio, AJ
Stradley, DA
Feeser, WS
Van Dyk, DE
Pitts, WJ
Earl, RA
Hobbs, F
Copeland, RA
Magolda, RL
Scherle, PA
Trzaskos, JM
机构
[1] Dupont Merck Res Labs, Inflammatory Dis Res, Wilmington, DE 19880 USA
[2] Dupont Merck Res Labs, Chem Enzymol, Wilmington, DE 19880 USA
[3] Dupont Merck Res Labs, Chem & Phys Sci, Wilmington, DE 19880 USA
关键词
D O I
10.1074/jbc.273.29.18623
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The compound U0126 (1,4-diamino-2,3-dicyano-1,4-bis[2-aminophenylthio]butadiene) was identified as an inhibitor of AP-1 transactivation in a cell-based reporter assay. U0126 was also shown to inhibit endogenous promoters containing AP-1 response elements but did not affect genes lacking an AP-1 response element in their promoters. These effects of U0126 result from direct inhibition of the mitogen-activated protein kinase kinase family members, MEK-1 and MEK-2. Inhibition is selective for MEK-1 and -2, as U0126 shows little, if any, effect on the kinase activities of protein kinase C, Abl, Raf, MEKK, ERK, JNK, MKK-3, MKK-4/SEK, MKK6, Cdk2, or Cdk4. Comparative kinetic analysis of U0126 and the MEK inhibitor PD098059 (Dudley, D. T., Pang, L., Decker, S. J., Bridges, A. J., and Saltiel, A. R. (1995) Proc. Natl. Acad. Sci U. S. A. 92, 7686-7689) demonstrates that U0126 and PD098059 are noncompetitive inhibitors with respect to both MEK substrates, ATP and ERK. We further demonstrate that the two compounds bind to S218E/S222D MEK in a mutually exclusive fashion, suggesting that they may share a common or overlapping binding site(s). Quantitative evaluation of the steady state kinetics of MEK inhibition by these compounds reveals that U0126 has approximately 100-fold higher affinity for Delta N3-S218E/S222D MEK than does PD098059. We further tested the effects of these compounds on the activity of wild type MEK isolated after activation from stimulated cells. Surprisingly, we observe a significant diminution in affinity of both compounds for wild type MEK as compared with the Delta N3-S218E/S222D mutant enzyme. These results suggest that the affinity of both compounds is mediated by subtle conformational differences between the two activated MEK forms. The MEK affinity of U0126, its selectivity for MEK over other kinases, and its cellular efficacy suggest that this compound will serve as a powerful tool for in vitro and cellular investigations of mitogen-activated protein kinase-mediated signal transduction.
引用
收藏
页码:18623 / 18632
页数:10
相关论文
共 50 条
  • [21] Regulation of mitogen-activated protein kinase by protein kinase C and mitogen-activated protein kinase phosphatase-1 in vascular smooth muscle
    Trappanese, Danielle M.
    Sivilich, Sarah
    Ets, Hillevi K.
    Kako, Farah
    Autieri, Michael V.
    Moreland, Robert S.
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 2016, 310 (11): : C921 - C930
  • [22] Redox-dependent dimerization of p38α mitogen-activated protein kinase with mitogen-activated protein kinase kinase 3
    Bassi, Rekha
    Burgoyne, Joseph R.
    DeNicola, Gian F.
    Rudyk, Olena
    DeSantis, Vittorio
    Charles, Rebecca L.
    Eaton, Philip
    Marber, Michael S.
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2017, 292 (39) : 16161 - 16173
  • [23] Molecular cloning and characterization of a novel protein kinase with a catalytic domain homologous to mitogen-activated protein kinase kinase kinase
    Wang, XHS
    Diener, K
    Jannuzzi, D
    Trollinger, D
    Tan, TH
    Lichenstein, H
    Zukowski, M
    Yao, ZB
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (49) : 31607 - 31611
  • [24] Protein kinase C and mitogen-activated protein kinase signalling in oligodendrocytes
    Stariha, RL
    Kim, SU
    [J]. MICROSCOPY RESEARCH AND TECHNIQUE, 2001, 52 (06) : 680 - 688
  • [25] Role of mitogen-activated protein kinase kinase 4 in cancer
    A J Whitmarsh
    R J Davis
    [J]. Oncogene, 2007, 26 : 3172 - 3184
  • [26] Role of mitogen-activated protein kinase kinase 4 in cancer
    Whitmarsh, A. J.
    Davis, R. J.
    [J]. ONCOGENE, 2007, 26 (22) : 3172 - 3184
  • [27] Dynamic Ubiquitination of the Mitogen-activated Protein Kinase Kinase (MAPKK) Ste7 Determines Mitogen-activated Protein Kinase (MAPK) Specificity
    Hurst, Jillian H.
    Dohlman, Henrik G.
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2013, 288 (26) : 18660 - 18671
  • [28] INCREASED EXPRESSION AND SUBCELLULAR TRANSLOCATION OF THE MITOGEN-ACTIVATED PROTEIN-KINASE KINASE AND MITOGEN-ACTIVATED PROTEIN-KINASE IN ALZHEIMERS-DISEASE
    ARENDT, T
    HOLZER, M
    GROSSMANN, A
    ZEDLICK, D
    BRUCKNER, MK
    [J]. NEUROSCIENCE, 1995, 68 (01) : 5 - 18
  • [29] MAMMALIAN MITOGEN-ACTIVATED PROTEIN-KINASE KINASE KINASE (MEKK) CAN FUNCTION IN A YEAST MITOGEN-ACTIVATED PROTEIN-KINASE PATHWAY DOWNSTREAM OF PROTEIN-KINASE-C
    BLUMER, KJ
    JOHNSON, GL
    LANGECARTER, CA
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (11) : 4925 - 4929
  • [30] Identification of mitogen-activated protein (MAP) kinase-activated protein kinase-3, a novel substrate of CSBP p38 MAP kinase
    McLaughlin, MM
    Kumar, S
    McDonnell, PC
    VanHorn, S
    Lee, JC
    Livi, GP
    Young, PR
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (14) : 8488 - 8492